Analysis of Survival of Pediatric Patients with Leukemias and Lymphomas in the Oncological Context: Epidemiological Study in the State of São Paulo, Brazil, 2000-2022
DOI:
https://doi.org/10.32635/2176-9745.RBC.2024v70n1.4473Keywords:
Survival Analysis, Diagnosis Leukemia, Diagnosis LymphomaAbstract
Introduction: The time taken for screening, detection and initiation of treatment is a determining factor for therapeutic management in oncology. The availability of reliable data guides decisions for public policies and evaluates compliance with these policies. Objective: To analyze the survival and outcomes of pediatric patients with leukemia and lymphoma from 2000 to 2022. Method: Epidemiological, descriptive study, with data extracted from Fundação Oncocentro do Estado de São Paulo, according to the International Classification of Childhood Cancer (ICCC). The time elapsed between the first consultation and diagnosis was evaluated, between diagnosis and the start of oncological treatment, and the survival of these patients, calculated according to the Peto-Peto test. Results: 12,030 cases were analyzed, 6,994 in males and 7,292 with leukemia. The probability of the time between consultation and diagnosis exceeds 30 days was 49.29% for leukemias and 76.31 for lymphomas, a significant result for treatment and relapses (p < 0.001) but not in relation to sex; the time between diagnosis and treatment exceeding 60 days was 38.04% for leukemias and 71.97% for lymphomas. Not undergoing treatment was significant (p < 0.001) while waiting for diagnosis after consultation for patients with leukemia and lymphomas, except surgery, chemotherapy and radiotherapy combined. Conclusion: Despite the advances, a considerable percentage of patients wait longer than expected for diagnosis and initiation of treatment, impacting their survival rates.
Downloads
References
Erdmann F, Frederiksen L, Bonaventure A, et al. Childhood cancer: survival, treatment modalities, late effects and improvements over time. Cancer Epidemiol 2021;71(Part B):101733. doi: https://doi.org/10.1016/j.canep.2020.101733 DOI: https://doi.org/10.1016/j.canep.2020.101733
Instituto Nacional de Câncer. Estimativa 2023: incidência de câncer no Brasil. Rio de Janeiro:INCA; 2023. [cited 2023 dez 1]. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2023.pdf
Observatório de Oncologia [Internet]. Indicadores da Oncologia. São Paulo: Observatório de Oncologia; [date unknown]. [cited 2023 dez 25]. Disponível em: https://observatoriodeoncologia.com.br/indicadoresda-oncologia/
Wild CP, Weiderpass E, Stewart BW, editors. World cancer report: cancer research for cancer prevention [Internet]. Lyon (FR): International Agency for Research on Cancer; 2020. [cited 2022 july 3]. Available from: http://publications.iarc.fr/586
Maia F. Services assisted to the oncological patient within the framework of the single health-SUS system. Extramuros. 2019 [cited 2023 dez];7(1):86-107. Available from: https://www.periodicos.univasf.edu.br/index.php/extramuros/article/view/941
Miller K, Fidler-Benaoudia M, Keegan T, et al. Cancer statistics for adolescents and young adults, 2020. CA: Cancer J Clin. 2020;70(6):443-59. doi: https://doi.org/10.3322/caac.21637. DOI: https://doi.org/10.3322/caac.21637
Nakata K, Ito Y, Magadi W, et al. Childhood cancer incidence and survival in Japan and England: a population-based study (1993-2010). Cancer Sci. 2017;109(2):422-34. doi: https://doi.org/10.1111/cas.13457 DOI: https://doi.org/10.1111/cas.13457
Presidência da República (BR). Lei 12.732, de 23 de novembro de 1992. Dispõe sobre o primeiro tratamento de paciente com neoplasia maligna comprovada e estabelece prazo para seu início. Diário Oficial da União. Brasília, DF. 1992 nov 23. [acesso 2023 abr 25]. Disponível em: https://www.planalto.gov.br/ccivil_03/_ato2011-2014/2012/lei/l12732.htm
Presidência da República (BR). Lei n° 13.896, de 30 de outubro de 2019. Altera a Lei nº 12.732, de 22 de novembro de 2012, para que os exames relacionados ao diagnóstico de neoplasia maligna sejam realizados no prazo de 30 (trinta) dias, no caso em que especifica [Internet]. Diário Oficial da União, Brasília, DF. 2019 out 31 [cited 2023 ago 20]; Seção I:1. Available from: http://www.planalto.gov.br/ccivil_03/_Ato2019-2022/2019/Lei/L13896.htm
Medeiros G, Teodózio C, Fabro E, et al. Factors associated with delay between diagnosis and initiation of breast cancer treatment: a cohort study with 204,130 cases in Brazil. Rev Bras Cancerol. 2020;66(3):e-09979. doi: https://doi.org/10.32635/2176-9745.RBC.2020v66n3.979 DOI: https://doi.org/10.32635/2176-9745.RBC.2020v66n3.979
Ribeiro C, Correa F, Migowski A. Short-term effects of the COVID-19 pandemic on cancer screening, diagnosis and treatment procedures in Brazil: a descriptive study, 2019-2020. Epidemiol Serv Saúde. 2022;31(1):e2021405. doi: http://dx.doi.org/10.1590/s1679-49742022000100010 DOI: https://doi.org/10.1590/s1679-49742022000100010
Steliarova-Foucher E, Stiller C, Lacour B, et al. International Classification of Childhood Cancer, third edition. Cancer. 2005;103(7):1457-67. doi: https://doi.org/10.1002/cncr.20910 DOI: https://doi.org/10.1002/cncr.20910
R: The R Project for Statistical Computing [Internet]. Version 4.3.0 [place unknown]: The R foundation. 2021 Nov 2 - [cited 2023 sept 6]. Available from: https://www.r-project.org/
Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457-81. doi: https://doi.org/10.2307/2281868 DOI: https://doi.org/10.1080/01621459.1958.10501452
Kleinbaum D, Klein M. Survival analysis: a selflearning text. 3rd rev. ed. Amesterdã: Elsevier; 1996. [cited 2023 sept 6]. Available from: https://link.springer.com/book/10.1007/978-1-4419-6646-9
Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Statist Soc A. 1972;135(2):185-207. doi: https://doi.org/10.2307/2344317 DOI: https://doi.org/10.2307/2344317
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995;57(1):289-300. doi: https://doi.org/10.1111/j.2517-6161.1995.tb02031.x DOI: https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
Conselho Nacional de Saúde (BR). Resolução n° 510, de 7 de abril de 2016. Dispõe sobre as normas aplicáveis a pesquisas em Ciências Humanas e Sociais cujos procedimentos metodológicos envolvam a utilização de dados diretamente obtidos com os participantes ou de informações identificáveis ou que possam acarretar riscos maiores do que os existentes na vida cotidiana, na forma definida nesta Resolução [Internet]. Diário Oficial da União, Brasília, DF. 2016 maio 24 [cited 2023 sept 6]; Seção I:44. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/cns/2016/res0510_07_04_2016.html
RHC: Registro Hospitalar de Câncer [Internet]. São Paulo: Fundação Oncocentro de São Paulo; 2023. [cited 2024 feb 25]. Available from: https://fosp.saude.sp.gov.br/fosp/diretoria-adjunta-de-informacao-e-epidemiologia/rhc-registro-hospitalar-de-cancer/banco-de-dados-do-rhc/
Steliarova-Foucher E, Colombet M, Ryes L, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18(6):719-31. doi: https://doi.org/10.1016/S1470-2045(17)30186-9. DOI: https://doi.org/10.1016/S1470-2045(17)30186-9
Siegel R, Miller K, Fuchs H, et al. Cancer statistics, 2022. CA: Cancer J Clin. 2022;72(1):7-33. doi: https://doi.org/10.3322/caac.21708 DOI: https://doi.org/10.3322/caac.21708
Churchman M, Qian M, Kronnie G, et al. Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia. Cancer Cell. 2018;33(5):937-48. doi: https://doi.org/10.1016/j.ccell.2018.03.021 DOI: https://doi.org/10.1016/j.ccell.2018.03.021
Grabois M, Oliveira E, Carvalho M. Childhood cancer and pediatric oncologic care in Brazil: access and equity. Cad. Saúde Pública 201;27(9):1711-20. doi: https://doi.org/10.1590/S0102-311X2011000900005 DOI: https://doi.org/10.1590/S0102-311X2011000900005
Paiva M, Paiva C. Study of the time between the diagnosis and the beginning of the treatment of children with cancer in a reference center in Paraíba [dissertação na Internet]. João Pessoa: Universidade Federal da Paraíba: 2018. [cited 2023 aug 24]. Available from: https://repositorio.ufpb.br/jspui/handle/123456789/15034
Furtado MM, Sousa TO, Wanderley AV, et al. Epidemiological profile of childhood cancer in patients attended at the regional hospital of Santarém-PA in the period from 2013 to 2015. Braz J Hea Rev. 2022;5(1):932-45. doi: https://doi.org/10.34119/ bjhrv5n1-079 DOI: https://doi.org/10.34119/bjhrv5n1-079
Hansen RP, Olesen F, Sorensen HT, et al. Socioeconomic patient characteristics predict delay in cancer diagnosis: a danish cohort study. BMC Health Serv Res. 2008; 8(49):1-16. doi: https://doi.org/10.1186/1472-6963-8-49 DOI: https://doi.org/10.1186/1472-6963-8-49
Stritter W, Rutert B, Eidenschink C, et al. Perception of integrative care in paediatric oncology - perspectives of parents and patients. Complement Ther Med 2021;56:102624. doi: https://doi.org/10.1016/j.ctim.2020.102624 DOI: https://doi.org/10.1016/j.ctim.2020.102624
Ferman S, Santos M, Ferreira J, et al. Childhood cancer mortality trends in Brazil, 1979-2008. Clinics 2013;68:219-24. doi: https://doi.org/10.6061/clinics/2013(02)OA16 DOI: https://doi.org/10.6061/clinics/2013(02)OA16
Santos D, Santos J, Araújo Y, et al. Analysis of early treatment of childhood cancer in Brazil. Rev Bras Cancerol. 2022;68(1):e-171637. doi: https://doi.org/10.32635/2176-9745.RBC.2022v68n1.1637 DOI: https://doi.org/10.32635/2176-9745.RBC.2022v68n1.1637
Xu Y, Stavrides-Eid M, Baig A, et al. Quantifying treatment delays in adolescents and young adults with cancer at McGill University. Curr Oncol. 2015;22(6):470-7. doi: https://doi.org/10.3747%2Fco.22.2724 DOI: https://doi.org/10.3747/co.22.2724
Coven S, Stanek J, Hollingsworth E, et al. Delays in diagnosis for children with newly diagnosed central nervous system tumors. Neurooncol Pract. 2018;5(4):227-33. doi: https://doi.org/10.1093%2Fnop%2Fnpy002 DOI: https://doi.org/10.1093/nop/npy002
Saraiva D, Santos S, Monteiro G. Leukemia mortality trends in children and adolescents in Brazilian state capitals: 1980-2015. Epidemiol Serv Saúde. 2018;27(3):e-2017310. doi: https://doi.org/10.5123/S1679-49742018000300004 DOI: https://doi.org/10.5123/S1679-49742018000300004
Araújo L, Rodrigues V, Silva M, et al. Demographic and clinical profile of cases of hematological neoplasms in children and adolescents. Rev Bras Cancerol. 2022;68(2):e-242356. doi: https://doi.org/10.32635/2176-9745.RBC.2022v68n2.2356 DOI: https://doi.org/10.32635/2176-9745.RBC.2022v68n2.2356
Soares M, Melanda F, Lima-Neto G, et al. Mortality trend and analysis of potential years of life lost due to leukemia and lymphoma in Brazil and Mato Grosso. Rev Bras Epidemiol 2022;25(1):e220008. doi: https://doi.org/10.1590/1980-549720220008.supl.1 DOI: https://doi.org/10.1590/1980-549720220008.supl.1
Feliciano S, Santos M, Pombo-de-oliveira M, et al. Cancer incidence and mortality among children and adolescents: a narrative review. Rev Bras Cancerol. 2018;64(3):389-96. doi: https://doi.org/10.32635/2176-9745.RBC.2018v64n3.45 DOI: https://doi.org/10.32635/2176-9745.RBC.2018v64n3.45
Atty A, Jardim B, Dias M, et al. Oncology-PANEL: tool for management. Rev Bras Cancerol. 2020;66(2):e-04827. doi: https://doi.org/10.32635/2176-9745.RBC.2020v66n2.827 DOI: https://doi.org/10.32635/2176-9745.RBC.2020v66n2.827
Mou J, Bolieu E, Pflugeisen B, et al. Delay in treatment after cancer diagnosis in adolescents and young adults: does facility transfer matter? J Adolesc Young Adult Oncol. 2019;8(3):243-53. doi: https://doi.org/10.1089/jayao.2018.0128 DOI: https://doi.org/10.1089/jayao.2018.0128
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.
